NCT05202327View on ClinicalTrials.gov

PDC-1421 Treatment in Adult Patients With ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 7, 2022

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions
Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

PDC-1421 Capsule

PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as the active ingredient.

DRUG

Placebo

The placebo contained corn starch.

Trial Locations (6)

112

Cheng Hsin General Hospital, Taipei

Taipei veterans General Hospital, Taipei

10002

National Taiwan University Hospital, Taipei

33425

Linkou chang Gung Memorial Hospital, Taoyuan District

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

ABVC BioPharma, Inc

UNKNOWN

lead

BioLite, Inc.

INDUSTRY